ID
stringlengths 11
11
| tags
stringlengths 10
777
| text
stringlengths 2
1.5k
| dataset_num
int64 1
3
| tokens
sequence | ner_tags
sequence |
---|---|---|---|---|---|
NCT02227199 | 1:25:chronic_disease | congestive heart failure | 1 | [
"congestive",
"heart",
"failure"
] | [
2,
2,
2
] |
NCT02209636 | 12:36:chronic_disease,, | History of congestive heart failure (EF < 35%) | 1 | [
"History",
"of",
"congestive",
"heart",
"failure",
"(",
"EF",
"<",
"35",
"%",
")"
] | [
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0
] |
NCT02188745 | 1:25:chronic_disease | congestive heart failure | 1 | [
"congestive",
"heart",
"failure"
] | [
2,
2,
2
] |
NCT02152995 | 44:68:chronic_disease, | History or evidence of current >= class II congestive heart failure as defined by the New York Heart Association (NYHA) functional classification system | 1 | [
"History",
"or",
"evidence",
"of",
"current",
">",
"=",
"class",
"II",
"congestive",
"heart",
"failure",
"as",
"defined",
"by",
"the",
"New",
"York",
"Heart",
"Association",
"(",
"NYHA",
")",
"functional",
"classification",
"system"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02143726 | ,,49:73:chronic_disease | New York Heart Association grade III or greater congestive heart failure | 1 | [
"New",
"York",
"Heart",
"Association",
"grade",
"III",
"or",
"greater",
"congestive",
"heart",
"failure"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2
] |
NCT02128906 | 16:40:chronic_disease | no symptomatic congestive heart failure | 1 | [
"no",
"symptomatic",
"congestive",
"heart",
"failure"
] | [
0,
0,
2,
2,
2
] |
NCT02124772 | 45:69:chronic_disease, | a history or evidence of current >=Class II congestive heart failure as defined by the New York Heart Association (NYHA) guidelines | 1 | [
"a",
"history",
"or",
"evidence",
"of",
"current",
">",
"=Class",
"II",
"congestive",
"heart",
"failure",
"as",
"defined",
"by",
"the",
"New",
"York",
"Heart",
"Association",
"(",
"NYHA",
")",
"guidelines"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02106650 | 1:25:chronic_disease,,, | congestive heart failure Class III/IV according to the New York Heart Association (NYHA) Functional Classification | 1 | [
"congestive",
"heart",
"failure",
"Class",
"III/IV",
"according",
"to",
"the",
"New",
"York",
"Heart",
"Association",
"(",
"NYHA",
")",
"Functional",
"Classification"
] | [
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02094118 | 11:35:chronic_disease | Prevalent congestive heart failure prior to randomization | 1 | [
"Prevalent",
"congestive",
"heart",
"failure",
"prior",
"to",
"randomization"
] | [
0,
2,
2,
2,
0,
0,
0
] |
NCT02081404 | ,,,22:46:chronic_disease | NYHA class III or IV congestive heart failure | 1 | [
"NYHA",
"class",
"III",
"or",
"IV",
"congestive",
"heart",
"failure"
] | [
0,
0,
0,
0,
0,
2,
2,
2
] |
NCT02070549 | ,44:68:chronic_disease, | History or evidence of current >= class II congestive heart failure as defined by the New York Heart Association (NYHA) functional classification system | 1 | [
"History",
"or",
"evidence",
"of",
"current",
">",
"=",
"class",
"II",
"congestive",
"heart",
"failure",
"as",
"defined",
"by",
"the",
"New",
"York",
"Heart",
"Association",
"(",
"NYHA",
")",
"functional",
"classification",
"system"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02058095 | 34:58:chronic_disease | no clinical signs or symptoms of congestive heart failure | 1 | [
"no",
"clinical",
"signs",
"or",
"symptoms",
"of",
"congestive",
"heart",
"failure"
] | [
0,
0,
0,
0,
0,
0,
2,
2,
2
] |
NCT01989585 | ,44:68:chronic_disease, | History or evidence of current >= class II congestive heart failure as defined by the New York Heart Association (NYHA) functional classification system | 1 | [
"History",
"or",
"evidence",
"of",
"current",
">",
"=",
"class",
"II",
"congestive",
"heart",
"failure",
"as",
"defined",
"by",
"the",
"New",
"York",
"Heart",
"Association",
"(",
"NYHA",
")",
"functional",
"classification",
"system"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01954316 | 27:51:chronic_disease,,, | Have clinical symptomatic congestive heart failure defined at >= Class II of the New York Heart Association functional classification system or LVEF < 50% at baseline | 1 | [
"Have",
"clinical",
"symptomatic",
"congestive",
"heart",
"failure",
"defined",
"at",
">",
"=",
"Class",
"II",
"of",
"the",
"New",
"York",
"Heart",
"Association",
"functional",
"classification",
"system",
"or",
"LVEF",
"<",
"50",
"%",
"at",
"baseline"
] | [
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01947673 | 22:46:chronic_disease | clinical evidence of congestive heart failure | 1 | [
"clinical",
"evidence",
"of",
"congestive",
"heart",
"failure"
] | [
0,
0,
0,
2,
2,
2
] |
NCT01943851 | ,43:67:chronic_disease | History or evidence of current >=Class II congestive heart failure as defined by New York Heart Association (NYHA) | 1 | [
"History",
"or",
"evidence",
"of",
"current",
">",
"=Class",
"II",
"congestive",
"heart",
"failure",
"as",
"defined",
"by",
"New",
"York",
"Heart",
"Association",
"(",
"NYHA",
")"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01919619 | 8:32:chronic_disease | Active congestive heart failure (New York Heart Association [NYHA] class III to IV) | 1 | [
"Active",
"congestive",
"heart",
"failure",
"(",
"New",
"York",
"Heart",
"Association",
"[",
"NYHA",
"]",
"class",
"III",
"to",
"IV",
")"
] | [
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01842399 | 7:31:chronic_disease | Known congestive heart failure now or in the past | 1 | [
"Known",
"congestive",
"heart",
"failure",
"now",
"or",
"in",
"the",
"past"
] | [
0,
2,
2,
2,
0,
0,
0,
0,
0
] |
NCT01811368 | 14:38:chronic_disease | uncontrolled congestive heart failure | 1 | [
"uncontrolled",
"congestive",
"heart",
"failure"
] | [
0,
2,
2,
2
] |
NCT01750567 | 12:36:chronic_disease,,, | History of congestive heart failure defined as NYHA class III or IV | 1 | [
"History",
"of",
"congestive",
"heart",
"failure",
"defined",
"as",
"NYHA",
"class",
"III",
"or",
"IV"
] | [
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT01670877 | ,122:146:chronic_disease | Testing for LVEF is not required for pre-registration, but patient must not have a recent LVEF < LLN or have symptoms of congestive heart failure | 1 | [
"Testing",
"for",
"LVEF",
"is",
"not",
"required",
"for",
"pre-registration",
",",
"but",
"patient",
"must",
"not",
"have",
"a",
"recent",
"LVEF",
"<",
"LLN",
"or",
"have",
"symptoms",
"of",
"congestive",
"heart",
"failure"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2
] |
NCT01568177 | 14:38:chronic_disease | uncontrolled congestive heart failure | 1 | [
"uncontrolled",
"congestive",
"heart",
"failure"
] | [
0,
2,
2,
2
] |
NCT01532687 | ,,17:41:chronic_disease, | Class III or IV congestive heart failure, as defined by the New York Heart Association (NYHA) | 1 | [
"Class",
"III",
"or",
"IV",
"congestive",
"heart",
"failure",
",",
"as",
"defined",
"by",
"the",
"New",
"York",
"Heart",
"Association",
"(",
"NYHA",
")"
] | [
0,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01526603 | ,,,,67:91:chronic_disease | shortening fraction ≥ 27% or ejection fraction ≥ 50%, no clinical congestive heart failure | 1 | [
"shortening",
"fraction",
"≥",
"27",
"%",
"or",
"ejection",
"fraction",
"≥",
"50",
"%",
",",
"no",
"clinical",
"congestive",
"heart",
"failure"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2
] |
NCT01515527 | 13:37:chronic_disease | symptomatic congestive heart failure | 1 | [
"symptomatic",
"congestive",
"heart",
"failure"
] | [
0,
2,
2,
2
] |
NCT01430390 | ,,,51:75:chronic_disease | New York Heart Association (NYHA) stage III or IV congestive heart failure | 1 | [
"New",
"York",
"Heart",
"Association",
"(",
"NYHA",
")",
"stage",
"III",
"or",
"IV",
"congestive",
"heart",
"failure"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2
] |
NCT01306045 | 38:62:chronic_disease | Ongoing or uncontrolled, symptomatic congestive heart failure (Class III or IV as defined by the NYHA functional classification system | 1 | [
"Ongoing",
"or",
"uncontrolled",
",",
"symptomatic",
"congestive",
"heart",
"failure",
"(",
"Class",
"III",
"or",
"IV",
"as",
"defined",
"by",
"the",
"NYHA",
"functional",
"classification",
"system"
] | [
0,
0,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01239160 | 14:38:chronic_disease | Diagnosis of congestive heart failure (uncontrolled) | 1 | [
"Diagnosis",
"of",
"congestive",
"heart",
"failure",
"(",
"uncontrolled",
")"
] | [
0,
0,
2,
2,
2,
0,
0,
0
] |
NCT00904046 | 12:36:chronic_disease | history of congestive heart failure NYHA class III or IV | 1 | [
"history",
"of",
"congestive",
"heart",
"failure",
"NYHA",
"class",
"III",
"or",
"IV"
] | [
0,
0,
2,
2,
2,
0,
0,
0,
0,
0
] |
NCT00715611 | 10:34:chronic_disease | No acute congestive heart failure | 1 | [
"No",
"acute",
"congestive",
"heart",
"failure"
] | [
0,
0,
2,
2,
2
] |
NCT00540761 | 1:25:chronic_disease | congestive heart failure | 1 | [
"congestive",
"heart",
"failure"
] | [
2,
2,
2
] |
NCT00432094 | 15:39:chronic_disease | decompensated congestive heart failure | 1 | [
"decompensated",
"congestive",
"heart",
"failure"
] | [
0,
2,
2,
2
] |
NCT00075387 | ,114:138:chronic_disease | Subjects with uncontrolled (over the last 30 days) clinically significant confounding medical conditions such as congestive heart failure | 1 | [
"Subjects",
"with",
"uncontrolled",
"(",
"over",
"the",
"last",
"30",
"days",
")",
"clinically",
"significant",
"confounding",
"medical",
"conditions",
"such",
"as",
"congestive",
"heart",
"failure"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2
] |
NCT00065676 | 1:25:chronic_disease | congestive heart failure | 1 | [
"congestive",
"heart",
"failure"
] | [
2,
2,
2
] |
NCT00001379 | 12:36:chronic_disease | history of congestive heart failure will not be eligible to receive | 1 | [
"history",
"of",
"congestive",
"heart",
"failure",
"will",
"not",
"be",
"eligible",
"to",
"receive"
] | [
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0
] |
NCT02891850 | 1:19:chronic_disease,21:56:chronic_disease | orthopedic disease, peripheral artery occlusive disease, which affects the patient's ability to walk | 1 | [
"orthopedic",
"disease",
",",
"peripheral",
"artery",
"occlusive",
"disease",
",",
"which",
"affects",
"the",
"patient",
"'s",
"ability",
"to",
"walk"
] | [
2,
2,
0,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02388685 | 1:12:treatment,16:36:treatment, | angioplasty or lumbar sympathectomy within 3 months of enrollment | 1 | [
"angioplasty",
"or",
"lumbar",
"sympathectomy",
"within",
"3",
"months",
"of",
"enrollment"
] | [
1,
0,
1,
1,
0,
0,
0,
0,
0
] |
NCT02544880 | 1:16:treatment,25:37:treatment | Prior radiation and any chemotherapy | 1 | [
"Prior",
"radiation",
"and",
"any",
"chemotherapy"
] | [
1,
1,
0,
0,
1
] |
NCT03181126 | ,73:85:treatment | Refractory is defined as persistent disease after at least 2 courses of chemotherapy | 1 | [
"Refractory",
"is",
"defined",
"as",
"persistent",
"disease",
"after",
"at",
"least",
"2",
"courses",
"of",
"chemotherapy"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT03153410 | 33:45:treatment, | Must have received last dose of chemotherapy at least 14 days or longer prior to entry into the study | 1 | [
"Must",
"have",
"received",
"last",
"dose",
"of",
"chemotherapy",
"at",
"least",
"14",
"days",
"or",
"longer",
"prior",
"to",
"entry",
"into",
"the",
"study"
] | [
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03139227 | ,,47:59:treatment | Must be > 1 year from pregnancy, lactation or chemotherapy | 1 | [
"Must",
"be",
">",
"1",
"year",
"from",
"pregnancy",
",",
"lactation",
"or",
"chemotherapy"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT03088709 | ,78:90:treatment | Less than twenty-one days have elapsed since the subject's last radiation or chemotherapy prior to conditioning | 1 | [
"Less",
"than",
"twenty-one",
"days",
"have",
"elapsed",
"since",
"the",
"subject",
"'s",
"last",
"radiation",
"or",
"chemotherapy",
"prior",
"to",
"conditioning"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0
] |
NCT03082612 | 42:54:treatment | Have completed surgery with no plans for chemotherapy | 1 | [
"Have",
"completed",
"surgery",
"with",
"no",
"plans",
"for",
"chemotherapy"
] | [
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT03082612 | 46:58:treatment | Treatment plans to include weekly outpatient chemotherapy | 1 | [
"Treatment",
"plans",
"to",
"include",
"weekly",
"outpatient",
"chemotherapy"
] | [
0,
0,
0,
0,
0,
0,
1
] |
NCT03051321 | 8:20:treatment | Active chemotherapy | 1 | [
"Active",
"chemotherapy"
] | [
0,
1
] |
NCT03011684 | 19:31:treatment | Has not yet begun chemotherapy | 1 | [
"Has",
"not",
"yet",
"begun",
"chemotherapy"
] | [
0,
0,
0,
0,
1
] |
NCT02913430 | 29:41:treatment | More than one prior line of chemotherapy in the metastatic setting | 1 | [
"More",
"than",
"one",
"prior",
"line",
"of",
"chemotherapy",
"in",
"the",
"metastatic",
"setting"
] | [
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0
] |
NCT02912572 | 33:45:treatment | patients who have only received chemotherapy in the adjuvant setting | 1 | [
"patients",
"who",
"have",
"only",
"received",
"chemotherapy",
"in",
"the",
"adjuvant",
"setting"
] | [
0,
0,
0,
0,
0,
1,
0,
0,
0,
0
] |
NCT02862938 | 19:31:treatment | Participant is on chemotherapy | 1 | [
"Participant",
"is",
"on",
"chemotherapy"
] | [
0,
0,
0,
1
] |
NCT02793583 | 1:13:treatment | chemotherapy | 1 | [
"chemotherapy"
] | [
1
] |
NCT02774421 | 28:40:treatment | who have been treated with chemotherapy at time of recurrence | 1 | [
"who",
"have",
"been",
"treated",
"with",
"chemotherapy",
"at",
"time",
"of",
"recurrence"
] | [
0,
0,
0,
0,
0,
1,
0,
0,
0,
0
] |
NCT02759146 | 12:24:treatment | Undergoing chemotherapy | 1 | [
"Undergoing",
"chemotherapy"
] | [
0,
1
] |
NCT02758847 | 1:13:treatment | chemotherapy | 1 | [
"chemotherapy"
] | [
1
] |
NCT02658565 | 23:35:treatment | Patients who received chemotherapy directed at the present disease | 1 | [
"Patients",
"who",
"received",
"chemotherapy",
"directed",
"at",
"the",
"present",
"disease"
] | [
0,
0,
0,
1,
0,
0,
0,
0,
0
] |
NCT02639208 | 79:91:treatment | either in the context of standard treatment or a clinical trial and including chemotherapy | 1 | [
"either",
"in",
"the",
"context",
"of",
"standard",
"treatment",
"or",
"a",
"clinical",
"trial",
"and",
"including",
"chemotherapy"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02635360 | 1:13:treatment | chemotherapy | 1 | [
"chemotherapy"
] | [
1
] |
NCT02603757 | 29:41:treatment | Patients who do not undergo chemotherapy | 1 | [
"Patients",
"who",
"do",
"not",
"undergo",
"chemotherapy"
] | [
0,
0,
0,
0,
0,
1
] |
NCT02589938 | 11:23:treatment | Receiving chemotherapy during study period | 1 | [
"Receiving",
"chemotherapy",
"during",
"study",
"period"
] | [
0,
1,
0,
0,
0
] |
NCT02565498 | 9:21:treatment | Planned chemotherapy for (neo)adjuvant treatment | 1 | [
"Planned",
"chemotherapy",
"for",
"(",
"neo",
")",
"adjuvant",
"treatment"
] | [
0,
1,
0,
0,
0,
0,
0,
0
] |
NCT02562716 | ,,,151:163:treatment | women/men of reproductive potential must have agreed to use an effective contraceptive method for up to 3 months after the final administered dose of chemotherapy | 1 | [
"women/men",
"of",
"reproductive",
"potential",
"must",
"have",
"agreed",
"to",
"use",
"an",
"effective",
"contraceptive",
"method",
"for",
"up",
"to",
"3",
"months",
"after",
"the",
"final",
"administered",
"dose",
"of",
"chemotherapy"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02536794 | 23:35:treatment | Patients who have had chemotherapy | 1 | [
"Patients",
"who",
"have",
"had",
"chemotherapy"
] | [
0,
0,
0,
0,
1
] |
NCT02536794 | ,36:48:treatment | have received at least one line of chemotherapy in the metastatic setting | 1 | [
"have",
"received",
"at",
"least",
"one",
"line",
"of",
"chemotherapy",
"in",
"the",
"metastatic",
"setting"
] | [
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0
] |
NCT02492867 | 37:49:treatment | Patients cannot tolerate concurrent chemotherapy | 1 | [
"Patients",
"can",
"not",
"tolerate",
"concurrent",
"chemotherapy"
] | [
0,
0,
0,
0,
0,
1
] |
NCT02481765 | 66:78:treatment | Intensive medical treatment means that the subject is undergoing chemotherapy for a hematologic/oncologic condition, is carrying a pacemaker or has been diagnosed with a cardiac anomaly which causes cardiac insufficiency not compensated with medications | 1 | [
"Intensive",
"medical",
"treatment",
"means",
"that",
"the",
"subject",
"is",
"undergoing",
"chemotherapy",
"for",
"a",
"hematologic/oncologic",
"condition",
",",
"is",
"carrying",
"a",
"pacemaker",
"or",
"has",
"been",
"diagnosed",
"with",
"a",
"cardiac",
"anomaly",
"which",
"causes",
"cardiac",
"insufficiency",
"not",
"compensated",
"with",
"medications"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02427841 | ,,,,156:168:treatment,,, | Women of child-bearing potential and men must be willing to use adequate contraception during the entire study and for 8 weeks following completion of all chemotherapy on study; this includes hormonal or barrier method, or abstinence | 1 | [
"Women",
"of",
"child-bearing",
"potential",
"and",
"men",
"must",
"be",
"willing",
"to",
"use",
"adequate",
"contraception",
"during",
"the",
"entire",
"study",
"and",
"for",
"8",
"weeks",
"following",
"completion",
"of",
"all",
"chemotherapy",
"on",
"study",
";",
"this",
"includes",
"hormonal",
"or",
"barrier",
"method",
",",
"or",
"abstinence"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02416206 | ,43:55:treatment | Within 9 months of the start of induction chemotherapy and no evidence of relapse or progression | 1 | [
"Within",
"9",
"months",
"of",
"the",
"start",
"of",
"induction",
"chemotherapy",
"and",
"no",
"evidence",
"of",
"relapse",
"or",
"progression"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT02359825 | 12:24:treatment | undergoing chemotherapy | 1 | [
"undergoing",
"chemotherapy"
] | [
0,
1
] |
NCT02320292 | 19:31:treatment | No indication for chemotherapy | 1 | [
"No",
"indication",
"for",
"chemotherapy"
] | [
0,
0,
0,
1
] |
NCT02315196 | ,81:93:treatment | imaging must have been performed no greater than 30 days prior to initiation of chemotherapy | 1 | [
"imaging",
"must",
"have",
"been",
"performed",
"no",
"greater",
"than",
"30",
"days",
"prior",
"to",
"initiation",
"of",
"chemotherapy"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02309892 | 10:22:treatment | Previous chemotherapy | 1 | [
"Previous",
"chemotherapy"
] | [
0,
1
] |
NCT02308709 | 12:24:treatment | Concurrent chemotherapy is allowed, but not required | 1 | [
"Concurrent",
"chemotherapy",
"is",
"allowed",
",",
"but",
"not",
"required"
] | [
0,
1,
0,
0,
0,
0,
0,
0
] |
NCT02303977 | ,41:53:treatment | Pregnant or breast-feeding patients, as chemotherapy is thought to present substantial risk to the fetus/infant | 1 | [
"Pregnant",
"or",
"breast-feeding",
"patients",
",",
"as",
"chemotherapy",
"is",
"thought",
"to",
"present",
"substantial",
"risk",
"to",
"the",
"fetus/infant"
] | [
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02227199 | 54:66:treatment | Patients must be anticipated to complete 2 cycles of chemotherapy | 1 | [
"Patients",
"must",
"be",
"anticipated",
"to",
"complete",
"2",
"cycles",
"of",
"chemotherapy"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02203513 | ,147:159:treatment | Patients should have recurrent platinum-resistant, defined as disease recurrence by imaging within 6 months of the last receipt of platinum-based chemotherapy | 1 | [
"Patients",
"should",
"have",
"recurrent",
"platinum-resistant",
",",
"defined",
"as",
"disease",
"recurrence",
"by",
"imaging",
"within",
"6",
"months",
"of",
"the",
"last",
"receipt",
"of",
"platinum-based",
"chemotherapy"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02159703 | 7:19:treatment, | Prior chemotherapy within the past 5 years | 1 | [
"Prior",
"chemotherapy",
"within",
"the",
"past",
"5",
"years"
] | [
0,
1,
0,
0,
0,
0,
0
] |
NCT02153229 | ,62:74:treatment | Subjects who have received more than 2 doses of neo-adjuvant chemotherapy | 1 | [
"Subjects",
"who",
"have",
"received",
"more",
"than",
"2",
"doses",
"of",
"neo-adjuvant",
"chemotherapy"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02135588 | ,40:52:treatment | At least 2 days from administration of chemotherapy | 1 | [
"At",
"least",
"2",
"days",
"from",
"administration",
"of",
"chemotherapy"
] | [
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02128906 | ,,53:65:treatment | Pregnant women are excluded from this study because chemotherapy | 1 | [
"Pregnant",
"women",
"are",
"excluded",
"from",
"this",
"study",
"because",
"chemotherapy"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02128906 | 24:36:treatment | breast feeding because chemotherapy | 1 | [
"breast",
"feeding",
"because",
"chemotherapy"
] | [
0,
0,
0,
1
] |
NCT02115295 | 74:86:treatment | Patient with documented hypersensitivity to any of the components of the chemotherapy program | 1 | [
"Patient",
"with",
"documented",
"hypersensitivity",
"to",
"any",
"of",
"the",
"components",
"of",
"the",
"chemotherapy",
"program"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0
] |
NCT02101736 | 21:33:treatment, | No myelosuppressive chemotherapy within 4 weeks of study entry | 1 | [
"No",
"myelosuppressive",
"chemotherapy",
"within",
"4",
"weeks",
"of",
"study",
"entry"
] | [
0,
0,
1,
0,
0,
0,
0,
0,
0
] |
NCT02099591 | 49:61:treatment | Patients currently receiving the first cycle of chemotherapy | 1 | [
"Patients",
"currently",
"receiving",
"the",
"first",
"cycle",
"of",
"chemotherapy"
] | [
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02091999 | 1:13:treatment | chemotherapy | 1 | [
"chemotherapy"
] | [
1
] |
NCT02037048 | ,40:52:treatment | for 90 days following the last dose of chemotherapy | 1 | [
"for",
"90",
"days",
"following",
"the",
"last",
"dose",
"of",
"chemotherapy"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02031250 | 43:55:treatment | Patients must be able to receive protocol chemotherapy in the judgment of the treating Medical Oncologist | 1 | [
"Patients",
"must",
"be",
"able",
"to",
"receive",
"protocol",
"chemotherapy",
"in",
"the",
"judgment",
"of",
"the",
"treating",
"Medical",
"Oncologist"
] | [
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01953900 | 53:65:treatment | Recovered from the acute toxic effects of all prior chemotherapy | 1 | [
"Recovered",
"from",
"the",
"acute",
"toxic",
"effects",
"of",
"all",
"prior",
"chemotherapy"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT01928589 | 73:85:treatment | Patient must have a Medical Oncology consult with the recommendation of chemotherapy | 1 | [
"Patient",
"must",
"have",
"a",
"Medical",
"Oncology",
"consult",
"with",
"the",
"recommendation",
"of",
"chemotherapy"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT01925573 | 58:70:treatment | 6 weeks since the completion of a nitrosourea-containing chemotherapy regimen | 1 | [
"6",
"weeks",
"since",
"the",
"completion",
"of",
"a",
"nitrosourea-containing",
"chemotherapy",
"regimen"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
1,
0
] |
NCT01919619 | ,,,,128:140:treatment, | diffusing capacity of the lung for carbon monoxide (DLCO) >= 40% within 3 months of study entry (or within 1 month if received chemotherapy within the past 3 months) | 1 | [
"diffusing",
"capacity",
"of",
"the",
"lung",
"for",
"carbon",
"monoxide",
"(",
"DLCO",
")",
">",
"=",
"40",
"%",
"within",
"3",
"months",
"of",
"study",
"entry",
"(",
"or",
"within",
"1",
"month",
"if",
"received",
"chemotherapy",
"within",
"the",
"past",
"3",
"months",
")"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0
] |
NCT01901562 | 15:27:treatment, | Have received chemotherapy in the last 12 months | 1 | [
"Have",
"received",
"chemotherapy",
"in",
"the",
"last",
"12",
"months"
] | [
0,
0,
1,
0,
0,
0,
0,
0
] |
NCT01896999 | 46:58:treatment | Patients must have relapsed after first line chemotherapy | 1 | [
"Patients",
"must",
"have",
"relapsed",
"after",
"first",
"line",
"chemotherapy"
] | [
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT01871766 | ,189:201:treatment | Participants treated on this protocol in the low or intermediate risk arm who experience disease progression prior to week 13 will transfer to the high risk arm and proceed with high risk chemotherapy starting at week 1 of the protocol | 1 | [
"Participants",
"treated",
"on",
"this",
"protocol",
"in",
"the",
"low",
"or",
"intermediate",
"risk",
"arm",
"who",
"experience",
"disease",
"progression",
"prior",
"to",
"week",
"13",
"will",
"transfer",
"to",
"the",
"high",
"risk",
"arm",
"and",
"proceed",
"with",
"high",
"risk",
"chemotherapy",
"starting",
"at",
"week",
"1",
"of",
"the",
"protocol"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT01859819 | 13:25:treatment | No previous chemotherapy | 1 | [
"No",
"previous",
"chemotherapy"
] | [
0,
0,
1
] |
NCT01807091 | ,,,87:99:treatment | Treatment-related mortality (TRM) score < 9.21 corresponding to a TRM rate of 3% when chemotherapy of similar intensity as proposed here is administered to inpatients | 1 | [
"Treatment-related",
"mortality",
"(",
"TRM",
")",
"score",
"<",
"9.21",
"corresponding",
"to",
"a",
"TRM",
"rate",
"of",
"3",
"%",
"when",
"chemotherapy",
"of",
"similar",
"intensity",
"as",
"proposed",
"here",
"is",
"administered",
"to",
"inpatients"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01754298 | 1:13:treatment | chemotherapy treatment | 1 | [
"chemotherapy",
"treatment"
] | [
1,
0
] |
NCT01730794 | 37:49:treatment | Immunosuppressed patients receiving chemotherapy | 1 | [
"Immunosuppressed",
"patients",
"receiving",
"chemotherapy"
] | [
0,
0,
0,
1
] |
NCT01703949 | ,63:75:treatment | Patients must be anticipated to complete at least 2 cycles of chemotherapy on study | 1 | [
"Patients",
"must",
"be",
"anticipated",
"to",
"complete",
"at",
"least",
"2",
"cycles",
"of",
"chemotherapy",
"on",
"study"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0
] |
NCT01690468 | 31:43:treatment | At least one prior regimen of chemotherapy, with no maximum number of chemotherapy cycles | 1 | [
"At",
"least",
"one",
"prior",
"regimen",
"of",
"chemotherapy",
",",
"with",
"no",
"maximum",
"number",
"of",
"chemotherapy",
"cycles"
] | [
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01676259 | 1:13:treatment | chemotherapy | 1 | [
"chemotherapy"
] | [
1
] |
NCT01620216 | 105:117:treatment | certain agents that prolong the corrected QT interval may be allowed but only after discussion with the chemotherapy pharmacist | 1 | [
"certain",
"agents",
"that",
"prolong",
"the",
"corrected",
"QT",
"interval",
"may",
"be",
"allowed",
"but",
"only",
"after",
"discussion",
"with",
"the",
"chemotherapy",
"pharmacist"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0
] |